Research ArticleOncology
Tumor-to-Blood Ratio for Assessment of Somatostatin Receptor Density in Neuroendocrine Tumors Using 68Ga-DOTATOC and 68Ga-DOTATATE
Ezgi Ilan, Irina Velikyan, Mattias Sandström, Anders Sundin and Mark Lubberink
Journal of Nuclear Medicine February 2020, 61 (2) 217-221; DOI: https://doi.org/10.2967/jnumed.119.228072
Ezgi Ilan
1Section of Nuclear Medicine and PET, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
2Medical Physics, Uppsala University Hospital, Uppsala, Sweden; and
Irina Velikyan
1Section of Nuclear Medicine and PET, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
3PET Centre, Medical Imaging Centre, Uppsala University Hospital, Uppsala, Sweden
Mattias Sandström
1Section of Nuclear Medicine and PET, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
2Medical Physics, Uppsala University Hospital, Uppsala, Sweden; and
Anders Sundin
1Section of Nuclear Medicine and PET, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
3PET Centre, Medical Imaging Centre, Uppsala University Hospital, Uppsala, Sweden
Mark Lubberink
1Section of Nuclear Medicine and PET, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
2Medical Physics, Uppsala University Hospital, Uppsala, Sweden; and

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 61, Issue 2
February 1, 2020
Tumor-to-Blood Ratio for Assessment of Somatostatin Receptor Density in Neuroendocrine Tumors Using 68Ga-DOTATOC and 68Ga-DOTATATE
Ezgi Ilan, Irina Velikyan, Mattias Sandström, Anders Sundin, Mark Lubberink
Journal of Nuclear Medicine Feb 2020, 61 (2) 217-221; DOI: 10.2967/jnumed.119.228072
Jump to section
Related Articles
Cited By...
- No citing articles found.